David DeLucia

Director of Finance/CFO at KYNTRA BIO, INC.

Net worth: 33 046 $ as of 2026-06-29

37 year

Health Technology

Consumer Services

Profile

David DeLucia is Chief Financial Officer & Senior Vice President at Kyntra Bio, Inc. since 2024.
Formerly, Mr. DeLucia was Director-Investor Relations at TherapeuticsMD, Inc. Education includes undergraduate studies at Stephen M.
Ross School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
KYNTRA BIO, INC. 0.11%	2026-06-05	4,377 ( 0.11% )	33 046 $	2026-06-29

David DeLucia active positions

Companies	Position	Start
KYNTRA BIO, INC.	Director of Finance/CFO	2024-12-15

All active positions of David DeLucia

Former positions of David DeLucia

Companies	Position	End
THERAPEUTICSMD, INC.	Investor Relations Contact	-

See the detail of David DeLucia's experience

Training of David DeLucia

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David DeLucia's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
FibroGen, Inc. FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs	Health Technology
Stephen M. Ross School of Business Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
TherapeuticsMD, Inc. TherapeuticsMD, Inc. Pharmaceuticals: MajorHealth Technology Manufactures women’s healthcare products	Health Technology